Protective effect of estrogen in endothelin-induced middle cerebral artery occlusion in female rats.
Estrogen is a powerful endogenous and exogenous neuroprotective agent in animal models of brain injury, including focal cerebral ischemia. Although this protection has been demonstrated in several different treatment and injury paradigms, it has not been demonstrated in focal cerebral ischemia induced by intraparenchymal endothelin-1 injection, a model with many advantages over other models of experimental focal ischemia. Reproductively mature female Sprague-Dawley rats were ovariectomized and divided into placebo and estradiol-treated groups. Two weeks later, halothane-anesthetized rats underwent middle cerebral artery (MCA) occlusion by interparenchymal stereotactic injection of the potent vasoconstrictor endothelin 1 (180pmoles/2microl) near the middle cerebral artery. Laser-Doppler flowmetry (LDF) revealed similar reductions in cerebral blood flow in both groups. Animals were behaviorally evaluated before, and 2 days after, stroke induction, and infarct size was evaluated. In agreement with other models, estrogen treatment significantly reduced infarct size evaluated by both TTC and Fluoro-Jade staining and behavioral deficits associated with stroke. Stroke size was significantly correlated with LDF in both groups, suggesting that cranial perfusion measures can enhance success in this model.
Glendenning
Michele L
ML
Department of Physiology, CA3145, Medical College of Georgia, 1120 15th Street, Augusta, GA 30912-3000, United States.
Lovekamp-Swan
Tara
T
Schreihofer
Derek A
DA
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D020520:Brain Infarction / Q000209:etiology / Q000517:prevention & control*; D004195:Disease Models, Animal; D019332:Endothelin-1; D004967:Estrogens / Q000627:therapeutic use*; D005260:Female; D005452:Fluoresceins; D020244:Infarction, Middle Cerebral Artery / Q000139:chemically induced* / Q000150:complications; D017078:Laser-Doppler Flowmetry / Q000379:methods; D009043:Motor Activity / Q000187:drug effects; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D009930:Organic Chemicals; D010052:Ovariectomy / Q000379:methods; D051381:Rats; D017207:Rats, Sprague-Dawley; D018709:Statistics, Nonparametric; D013778:Tetrazolium Salts
D019332:Endothelin-1; D004967:Estrogens; D005452:Fluoresceins; D018696:Neuroprotective Agents; D009930:Organic Chemicals; D013778:Tetrazolium Salts; C435731:fluoro jade; C009591:triphenyltetrazolium
Neuropharmacology. 2000 Mar 3;39(5):777-87
10699444
Stroke. 1989 Jan;20(1):84-91
2643202
Stroke. 2001 Sep;32(9):2143-8
11546909
Brain Res. 2005 Sep 21;1056(2):158-67
16125154
J Cereb Blood Flow Metab. 1994 Mar;14(2):337-42
8113329
J Neurosci Res. 2006 Feb 15;83(3):469-75
16397902
Cell Mol Neurobiol. 1993 Feb;13(1):15-23
8458060
Neurosci Lett. 1996 Jan 5;202(3):209-13
8848268
Drug Discov Today. 2008 Mar;13(5-6):254-60
18342802
Stroke. 2003 Feb;34(2):338-41
12574529
Exp Neurol. 2006 Oct;201(2):324-34
16740259
Brain Res. 2001 Jan 5;888(1):138-149
11146060
J Cereb Blood Flow Metab. 2006 Sep;26(9):1103-13
16437060
J Neurosci Methods. 1995 Aug;60(1-2):125-31
8544471
Trends Endocrinol Metab. 2003 Jul;14(5):228-35
12826329
Stroke. 1996 Dec;27(12):2282-6
8969794
Neuropathol Appl Neurobiol. 1998 Dec;24(6):487-97
9888159
J Neurosci Methods. 2002 Aug 30;118(2):199-206
12204310
Magn Reson Med. 2001 Oct;46(4):827-30
11590661
Eur J Pharmacol. 2001 Jan 5;411(1-2):71-83
11137861
Am J Physiol Heart Circ Physiol. 2007 Jan;292(1):H245-50
17213481
Neuropharmacology. 2004 Jul;47(1):146-55
15165842
J Cereb Blood Flow Metab. 1990 Mar;10(2):290-3
1689322
Life Sci. 2003 Oct 10;73(21):2665-74
13679235
J Cereb Blood Flow Metab. 1993 Sep;13(5):865-71
8360292
Neurosci Lett. 1999 Oct 8;273(3):191-4
10515191
J Neurosci Methods. 2007 May 15;162(1-2):14-8
17197033
J Neurol Sci. 1997 Dec 9;153(1):8-11
9455971
Brain Res. 1995 Mar 27;675(1-2):20-6
7796130
J Neurosci. 1995 Jul;15(7 Pt 2):5372-8
7623159
Brain Res. 2007 Jul 23;1159:54-66
17582385
J Neurocytol. 2000 May-Jun;29(5-6):401-10
11424956
Brain Res. 1999 Oct 2;843(1-2):105-11
10528116
Cephalalgia. 2006 Jan;26(1):33-42
16396664
Neurochem Res. 1999 Dec;24(12):1499-505
10591398
Neurosci Lett. 1995 Feb 6;185(1):65-9
7731557
Behav Brain Res. 2006 Oct 16;173(2):171-80
16899307
Dev Neurosci. 2005 Mar-Aug;27(2-4):112-20
16046844
Neurosci Lett. 2007 Mar 26;415(2):149-53
17239538
Brain Res. 2007 Jun 11;1153:58-67
17466282
Neuroscience. 2006 Aug 11;141(1):27-33
16690215
Hypertension. 2004 Jul;44(1):78-82
15159380
Stroke. 2001 Nov;32(11):2648-57
11692030
Br J Pharmacol. 2003 Sep;140(1):195-201
12967949